Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in Adult Patients with Cholinergic Urticaria
NCT03749148Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2018
- Primary completion
- Feb 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in Cholinergic Urticaria (CU), sponsored by Charité – Universitätsmedizin Berlin. Started Dec 2018; status: completed.
02
Drugs
03
Conditions
Cholinergic Urticaria (CU)
Beyond the preview
Go deeper on NCT03749148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03749148.